Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Yamashita Health Care Holdings EV-to-EBIT?
Yamashita Health Care HoldingsTSE:9265 68 EV-to-EBIT is 5.43 as of Sep. 16, 2026, which is 84% above its 10-year median of 2.95. GuruFocus rates TSE:9265 with a GF Score™ of 68/100 and a GF Value™ of 円2,968.81 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 98 Medical Distribution companies, Yamashita Health Care Holdings ranks better than 84.69% on this metric.
Yamashita Health Care Holdings (TSE:9265) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Yamashita Health Care Holdings's Enterprise Value for the quarter that ended in May. 2026 was 円3,529 Mil.
Yamashita Health Care Holdings's EBIT for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円935 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yamashita Health Care Holdings EV-to-EBIT Related Terms
Yamashita Health Care Holdings EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Yamashita Health Care Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yamashita Health Care Holdings EV-to-EBIT vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Yamashita Health Care Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Yamashita Health Care Holdings's EV-to-EBIT falls into.
Yamashita Health Care Holdings's current Enterprise Value is 円5,079 Mil.
Yamashita Health Care Holdings's EBIT for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円935 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yamashita Health Care Holdings (TSE:9265) has a EV-to-EBIT of 5.43 as of Sep. 16, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Yamashita Health Care Holdings and its competitors. This is 84% above median its historical median of 2.95. Over the past decade, Yamashita Health Care Holdings' EV-to-EBIT has ranged from 0.15 to 22.93. According to the industry distribution chart, Yamashita Health Care Holdings ranks #15 out of 98 companies in the Medical Distribution industry, placing it in the top 15.3%.
Is Yamashita Health Care Holdings' EV-to-EBIT too high?
Yamashita Health Care Holdings' current EV-to-EBIT of 5.43 is 84% above median its 10-year median of 2.95. Over the past 10 years, this metric has ranged from a low of 0.15 to a high of 22.93. The Medical Distribution industry median EV-to-EBIT is 11.78. Yamashita Health Care Holdings' value of 5.43 is 53.9% below this industry median. Based on the distribution chart, Yamashita Health Care Holdings ranks #15 out of 98 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Yamashita Health Care Holdings has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yamashita Health Care Holdings' EV-to-EBIT compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Yamashita Health Care Holdings ranks #15 out of 98 companies for EV-to-EBIT. This places Yamashita Health Care Holdings in the top 15% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 11.78. Yamashita Health Care Holdings' value of 5.43 is 53.9% below this benchmark. Historically, Yamashita Health Care Holdings' own EV-to-EBIT has ranged from 0.15 to 22.93 over the past decade. While the company's 10-year median is 2.95 vs. the industry median of 11.78, Yamashita Health Care Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Distribution company?
The median EV-to-EBIT among Medical Distribution companies is 11.78, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yamashita Health Care Holdings's current EV-to-EBIT of 5.43 is 53.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Yamashita Health Care Holdings and its competitors. For the Medical Distribution industry, the median EV-to-EBIT is 11.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yamashita Health Care Holdings's current EV-to-EBIT is 5.43, which is 84% above median its own 10-year median of 2.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yamashita Health Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Yamashita Health Care Holdings (TSE:9265) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,968.81, compared to a current price of 円3,620.00 — trading 21.9% above its estimated fair value. The current EV-to-EBIT is 5.43, which is 84% above median its 10-year median of 2.95 and 53.9% below the Medical Distribution industry median of 11.78. Yamashita Health Care Holdings' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Yamashita Health Care Holdings (TSE:9265), the current EV-to-EBIT is 5.43 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yamashita Health Care Holdings (TSE:9265) Overvalued in 2026?
Based on GuruFocus' analysis, Yamashita Health Care Holdings stock appears to be overvalued.
The current stock price of 円3,620.00 is trading 21.9% above its estimated GF Value™ of 円2,968.81.
GuruFocus considers Yamashita Health Care Holdings to be Modestly Overvalued.
Key valuation signals for TSE:9265:
EV-to-EBIT: 5.43 (84% above median its 10-year median of 2.95)
GF Value™: 円2,968.81 vs. price of 円3,620.00 (21.9% above fair value)
Industry Position: 53.9% below the Medical Distribution median (#15 of 98)
No single metric tells the full story. See the TSE:9265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yamashita Health Care Holdings Inc is a Japan-based medical equipment wholesale company that sells medical equipment for medical institutions within the Kyushu area. The company is also engaged in the manufacture, sale, leasing, and rental of optical instruments, physicochemical instruments, analytical instruments, measuring instruments, health equipment, exercise equipment, nursing care equipment, animal medical equipment, and veterinary drugs.
68GF Score
Get the complete analysis for TSE:9265
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9265 has been successfully added to your 
